pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
onclive·May 7·1 min read
save

Study Finds Screening Gap for HTLV-1 Linked Leukemia in US Caribbean-Born Communities

May 7, 2026·read at onclive ↗Positive

Researchers at Sylvester Comprehensive Cancer Center have highlighted a gap in screening for adult T‑cell leukemia/lymphoma (ATLL) that could be addressed by preventing mother‑to‑child transmission of HTLV‑1. The analysis focuses on U.S. populations where the virus is more prevalent, particularly among individuals born in the Caribbean.

Data show that non‑Hispanic Caribbean‑born residents have more than a 30‑fold higher incidence of ATLL compared with U.S. or Canada‑born groups, with Florida emerging as a hotspot due to its large Caribbean community. Since 2000, tens of thousands of births have occurred to mothers from HTLV‑1 endemic regions, approaching one million nationwide.

The study suggests that many ATLL cases are currently misclassified as peripheral T‑cell lymphoma not otherwise specified (PTCL‑NOS), which masks the true disease burden. Sensitivity analyses reallocating these misdiagnosed cases nearly double the estimated ATLL incidence among Caribbean‑born individuals.

The authors propose targeted prenatal HTLV‑1 screening based on maternal country of birth, combined with breastfeeding counseling, as a practical prevention strategy. This approach mirrors Japan’s successful nationwide program that led to a decline in ATLL cases.

source

This writeup was produced by pharmadog from original reporting by onclive.

Original headline: “Sylvester Comprehensive Cancer Center Identifies a Screening Gap to Prevent a Type of Leukemia in the U.S.”

read at onclive ↗
2,368 words · retrieved May 7
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
AMICUS THERAPEUTICS, INC.2Ultragenyx Pharmaceutical Inc.2
drugs
icosapent ethyl3Novel Therapeuticsacituzumab govitecan
topics
Oncology43Breast Cancer10HER28NSCLC5Hematology4TROP-23Antibody-Drug Conjugate (ADC)2Infectious Disease2Oncolytic Virus2Prostate Cancer2Pulmonology2Radioligand Therapy2Rare Disease2AMDAMLBispecific AntibodyCRL (Complete Response Letter)Diabetic Macular EdemaEGFREndocrinology & MetabolismGlioblastomaImmunologyMelanomaSmall MoleculeWomen's Health

related stories

  • May 11MimiVax and Roswell Park Open Phase 2 Trial of SurVaxM for Patients with Metastatic Neuroendocrine Tumorsonclive
  • May 6Disease Assessment and Mutational Testing in Progressive CLLonclive
  • May 6Dr Pant on the Mechanism of Action of Daraxonrasib in PDAConclive
  • May 12Dr Parikh on the Feasibility and Importance of Immunotherapy Trials in Anal Canceronclive
  • May 10Five Under 5: Top Oncology Videos for the Week of 5/3onclive